menu
    • menu

    Company profile for Full-Life Technologies

    NEW Drugs in Dev: 2
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Full-Life technologies limited (“Full-Life”) is a fully integrated global Nuclear Health company headquartered in Shanghai with operations in Europe. We seek to own the entire value chain for radio-ligand production, research, development and commercialization in order to deliver clinical impact for patients. Our core platform seeks to attack the two core issues that exist in radiopharmaceuticals today: 1) the ability to p...
    Full-Life technologies limited (“Full-Life”) is a fully integrated global Nuclear Health company headquartered in Shanghai with operations in Europe. We seek to own the entire value chain for radio-ligand production, research, development and commercialization in order to deliver clinical impact for patients. Our core platform seeks to attack the two core issues that exist in radiopharmaceuticals today: 1) the ability to produce in high quality and quantity radioisotope to meeting tomorrow’s needs and 2) innovative translational and biology research platform targeting the radio-pharma treatments of tomorrow.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Full-Life TechnologiesChina Flag
    Country
    Country
    China
    Address
    Address
    Room A1306, 13th Floor, Building 3 No. 702, Zhongke Road Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.full-life.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/full-life-technologies/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Full-Life Raises $150M for Clinical Assets & Mfg Capabilities
    Full-Life Raises $150M for Clinical Assets & Mfg Capabilities

    19 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/full-life-technologies-announces-us150-million-financing-to-accelerate-multiple-clinical-stage-assets-and-manufacturing-capabilities-302774873.html

    PR NEWSWIRE
    19 May 2026
    Share Share
    Full-Life Raises $150M; Quince Reboots with Pulmonary Drug
    Full-Life Raises $150M; Quince Reboots with Pulmonary Drug

    19 May 2026

    // ENDPOINTS

    https://endpoints.news/full-life-technologies-raises-150m-quince-finds-a-new-life/

    ENDPOINTS
    19 May 2026
    Share Share
    Full-Life Technologies Secures $77M To Advance Radiopharma
    Full-Life Technologies Secures $77M To Advance Radiopharma

    30 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/full-life-technologies-announces-us77-million-financing-to-accelerate-development-of-its-radiopharmaceutical-pipeline-and-manufacturing-capabilities-302569126.html

    PR NEWSWIRE
    30 Sep 2025
    Share Share
    Full-Life Technologies Appoints Edward Myles To Board Of Directors
    Full-Life Technologies Appoints Edward Myles To Board Of Directors

    21 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/full-life-technologies-announces-the-appointment-of-edward-ted-myles-to-its-board-of-directors-302202131.html

    PR NEWSWIRE
    21 Jul 2024
    Share Share
    Full-Life And SK Biopharm License Novel Solid Tumor Therapy
    Full-Life And SK Biopharm License Novel Solid Tumor Therapy

    17 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/full-life-technologies-sk-biopharmaceuticals-enter-licensing-agreement-for-novel-therapeutic-targeting-multiple-solid-tumors-302197884.html

    PR NEWSWIRE
    17 Jul 2024
    Share Share
    SK Signs $572M Deal With Full-Life For Radiopharma Leadership
    SK Signs $572M Deal With Full-Life For Radiopharma Leadership

    17 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/sk-inks-572m-deal-full-life-prospect-advancing-push-become-asias-radiopharma-leader

    FIERCE BIOTECH
    17 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search